BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2967626)

  • 21. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
    Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alpha human atrial natriuretic polypeptide on the systemic hemodynamics and coronary circulation in patients with ischemic heart disease.
    Serizawa T; Kohmoto O; Iizuka M; Hirata Y; Matsuoka H; Ohya T; Kimura Y; Sato H; Takahashi T; Masuo M
    Jpn Circ J; 1988 Oct; 52(10):1107-13. PubMed ID: 2974890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure.
    Magorien RD; Brown GP; Unverferth DV; Nelson S; Boudoulas H; Bambach D; Leier CV
    Circulation; 1982 Mar; 65(3):528-33. PubMed ID: 7055874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial natriuretic peptide attenuates pacing-induced myocardial ischemia during general anesthesia in patients with coronary artery disease.
    Valsson F; Lundin S; Kirnö K; Hedner T; Houltz E; Saito Y; Ricksten SE
    Anesth Analg; 1999 Feb; 88(2):279-85. PubMed ID: 9972741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
    Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.
    Cody RJ; Atlas SA; Laragh JH; Kubo SH; Covit AB; Ryman KS; Shaknovich A; Pondolfino K; Clark M; Camargo MJ
    J Clin Invest; 1986 Nov; 78(5):1362-74. PubMed ID: 2945832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure.
    De Marco T; Daly PA; Liu M; Kayser S; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1131-8. PubMed ID: 3033043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different hemodynamic effects of atrial natriuretic factor and nitroglycerin in rats with congestive heart failure.
    Chien YW; Trippodo NC; Frohlich ED
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1481-7. PubMed ID: 2532483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary vasodilatation and improved myocardial lactate metabolism after angiotensin converting enzyme inhibition with cilazapril in patients with congestive heart failure.
    Kiowski W; Zuber M; Elsasser S; Erne P; Pfisterer M; Burkart F
    Am Heart J; 1991 Nov; 122(5):1382-8. PubMed ID: 1683143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between exogenous atrial natriuretic peptide and hemodynamics in dogs with congestive heart failure produced by experimental mitral regurgitation.
    Asano K; Masuda K; Okumura M; Kadosawa T; Fujinaga T
    J Vet Med Sci; 2001 Mar; 63(3):243-50. PubMed ID: 11307923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in atrial natriuretic factor during preload reduction with nitroglycerin in patients with congestive heart failure.
    Keller N; Sykulski R; Thamsborg G; Storm T; Larsen J
    Clin Physiol; 1988 Feb; 8(1):57-64. PubMed ID: 2964972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
    Sanderson JE; Chan WW; Hung YT; Chan SK; Shum IO; Raymond K; Woo KS
    Br Heart J; 1995 Nov; 74(5):502-7. PubMed ID: 8562234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
    Grose R; Strain J; Greenberg M; LeJemtel TH
    J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
    Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial effects of prostaglandin E1 on myocardial energetics and pump performance in severe CHF.
    Awan NA; Needham KE; Evenson MK; Hermanovich J; Gradman M; Mason DT
    Acta Med Scand Suppl; 1981; 652():169-72. PubMed ID: 6949463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous and oral prenalterol in congestive heart failure. Effects on systemic and coronary hemodynamics and myocardial catecholamine balance.
    Wahr DW; Swedberg K; Rabbino M; Hoyle MJ; Curran D; Parmley WW; Chatterjee K
    Am J Med; 1984 Jun; 76(6):999-1005. PubMed ID: 6731471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous nesiritide on human coronary vasomotor regulation and myocardial oxygen uptake.
    Michaels AD; Klein A; Madden JA; Chatterjee K
    Circulation; 2003 Jun; 107(21):2697-701. PubMed ID: 12742984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of calcitonin gene-related peptide on cardiac contractility, coronary hemodynamics and myocardial energetics in idiopathic dilated cardiomyopathy.
    Dubois-Randé JL; Merlet P; Benvenuti C; Sediame S; Macquin-Mavier I; Chabrier E; Braquet P; Castaigne A; Adnot S
    Am J Cardiol; 1992 Oct; 70(9):906-12. PubMed ID: 1388329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease.
    Bersin RM; Chatterjee K; Arieff AI
    Am J Med; 1989 Jul; 87(1):7-14. PubMed ID: 2741982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.